NCT03077828 2023-06-02
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Northwestern University
Phase 2 Unknown
Clinical Trials
27 trialsNCT02099175 2023-03-13
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT02099188 2023-03-13
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT04012827 2022-09-07
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT03736616 2022-07-22
Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
Swedish Medical Center
Phase 2 Unknown
NCT05049473 2021-09-20
Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.
PETHEMA Foundation
Phase 2 Unknown
NCT02445404 2020-10-22
Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL
Samsung Medical Center
Phase 2 Unknown
NCT02544425 2020-10-22
VIDL+ASCT
Samsung Medical Center
Phase 2 Unknown
NCT04356872 2020-07-14
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown
NCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT04126811 2019-10-15
Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT03383406 2017-12-26
IVAM
Asan Medical Center
Phase 2 Unknown
NCT02812654 2016-06-24
Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
AC Camargo Cancer Center
Phase 2 Unknown
NCT02771743 2016-05-24
Response-based Treatment of High-risk Neuroblastoma
Samsung Medical Center
Phase 2 Unknown
NCT00718484 2014-01-30
PICASSO
Alaunos Therapeutics
Phase 2 Unknown
NCT00003284 2014-01-06
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00012311 2014-01-06
Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00002531 2013-09-17
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00669812 2013-08-26
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00974792 2013-08-26
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00002532 2013-08-07
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00025064 2013-08-07
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00026078 2013-08-07
Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01749072 2012-12-13
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
Peking Union Medical College Hospital
Phase 2 Unknown
NCT00790244 2011-07-06
SSGXX
Oslo University Hospital
Phase 2 Unknown
NCT01148173 2010-06-22
High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas
Charite University, Berlin, Germany
Phase 2 Unknown
NCT00127049 2006-09-08
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Unknown